Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells

XBP-1 regulates signal transduction, transcription factors and bone marrow colonization in B cells

Thumbnail Image
Download
Name

Ploegh_XBP-1 regulates.pdf

Size

1.64 MB

Format

Adobe PDF

Checksum (MD5)

0f346e01dc20c5d5f28b3e5dfe13c5fa

Author(s)
Hu, Chih-Chi Andrew
•
Dougan, Stephanie K.
•
McGehee, Annette M.
•
Ploegh, Hidde
•
Love, John C
Date Issued
April 2009
Journal
EMBO Journal
Publisher
Nature Publishing Group
Citation
Hu, Chih-Chi Andrew et al. “XBP-1 Regulates Signal Transduction, Transcription Factors and Bone Marrow Colonization in B Cells.” The EMBO Journal 28.11 (2009): 1624–1636. © 2012 European Molecular Biology Organization
Version
Final published version
Abstract
XBP-1, a transcription factor that drives the unfolded protein response (UPR), is activated in B cells when they differentiate to plasma cells. Here, we show that in the B cells, whose capacity to secrete IgM has been eliminated, XBP-1 is induced normally on induction of differentiation, suggesting that activation of XBP-1 in B cells is a differentiation-dependent event, but not the result of a UPR caused by the abundant synthesis of secreted IgM. Without XBP-1, B cells fail to signal effectively through the B-cell receptor. The signalling defects lead to aberrant expression of the plasma cell transcription factors IRF4 and Blimp-1, and altered levels of activation-induced cytidine deaminase and sphingosine-1-phosphate receptor. Using XBP-1-deficient/Blimp-1-GFP transgenic mice, we find that XBP-1-deficient B cells form antibody-secreting plasmablasts in response to initial immunization; however, these plasmablasts respond ineffectively to CXCL12. They fail to colonize the bone marrow and do not sustain antibody production. These findings define the role of XBP-1 in normal plasma cell development and have implications for management of B-cell malignancies.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Massachusetts Institute of Technology. Department of Chemical Engineering
Whitehead Institute for Biomedical Research
Terms of Use
Creative Commons Attribution
http://creativecommons.org/licenses/by/3.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/74263
DOI of Published Version
https://doi.org/10.1038/emboj.2009.117
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.